Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial.
Garant A, Kavan P, Martin AG, Azoulay L, Vendrely V, Lavoie C, Vasilevsky CA, Boutros M, Faria J, Nguyen TN, Ferland E, Des Groseilliers S, Cloutier AS, Diec H, Drolet S, Richard C, Batist G, Vuong T.
Garant A, et al.
Radiother Oncol. 2021 Feb;155:237-245. doi: 10.1016/j.radonc.2020.11.008. Epub 2020 Nov 19.
Radiother Oncol. 2021.
PMID: 33220397
Clinical Trial.